Cannabis Bioscience International Holdings, Inc. Appoints Veteran Financier Andy Trivedi to Its Board of Directors, Strengthening Capital Strategy and Growth Outlook
MWN-AI** Summary
Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a biomedical cannabis research and development company, has strengthened its leadership with the appointment of veteran financier Andy Trivedi to its Board of Directors. This strategic move, announced on October 6, 2025, aims to enhance the company's capital strategy and growth outlook amid the evolving landscape of the biomedical cannabis industry.
Mr. Trivedi, who holds an MBA and brings over 20 years of leadership experience, has a background that spans Fortune 500 companies and emerging growth sectors. Currently serving as Chief Financial Officer at Newable Power LLC, Mr. Trivedi has led financial planning and capital development for high-growth ventures. His expertise in capital raising and financial structuring is expected to play a critical role in CBIH's efforts to scale operations and innovate within the sector.
Cannabis Bioscience's Treasurer, John Jones, emphasized that Mr. Trivedi's experience in navigating complex financial markets will facilitate the opening of new avenues for support and strategic partnerships. These initiatives are essential as the company seeks institutional partners and aims to drive its medical cannabis research forward. Mr. Trivedi's past roles in major corporations like Hewlett-Packard and Siemens underline his capability to build scalable business models and secure investor engagement.
In addition to his corporate credentials, Mr. Trivedi is recognized for his commitment to veteran initiatives and small business development. His appointment is seen as timely, providing CBIH with the financial leadership necessary to ensure successful product rollouts and underpinning the company’s mission of enhancing patient care through cannabinoid-driven treatments. With this addition to its governance, CBIH is well-positioned to leverage upcoming opportunities and deliver sustained value to its shareholders.
MWN-AI** Analysis
The recent appointment of Andy Trivedi to the Board of Directors at Cannabis Bioscience International Holdings, Inc. (CBIH) represents a pivotal moment in the company’s strategic direction, particularly in light of the evolving biomedical cannabis landscape. As a seasoned financier with extensive experience across multiple sectors, Trivedi's expertise can provide a much-needed infusion of financial acumen, essential for navigating the complexities of capital raising in this industry.
Mr. Trivedi's background in Fortune 500 firms combined with his role at Newable Power LLC positions him as a valuable asset in guiding CBIH's capital strategy. His proven track record in financial structuring and business model scalability suggests that he could effectively facilitate the capital required to overcome resource constraints that have previously hindered product rollouts. This signals potential investors that CBIH is taking proactive steps to bolster its financial foundation, a crucial element for any growth-oriented entity in the competitive cannabis sector.
For shareholders, this appointment is expected to enhance long-term value, as CBIH focuses on expanding operational capacity and advancing its product development efforts. The medical cannabis industry is poised for exponential growth, yet companies need robust financial leadership to capitalize on opportunities amid regulatory and market challenges. Trivedi's role could be instrumental in forming strategic partnerships and attracting institutional investments, thereby strengthening CBIH’s market position.
Nevertheless, investors should remain cautious and aware of the risks outlined in CBIH's filings. The market remains volatile, and potential investors should conduct thorough due diligence. In summary, while the appointment of Trivedi bodes well for CBIH’s future, it’s imperative to monitor the company's execution of its growth strategy in the coming quarters.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Houston, Texas--(Newsfile Corp. - October 6, 2025) - Cannabis Bioscience International Holdings, Inc., (OTCID: CBIH), a publicly traded biomedical cannabis research and development company listed on the OTC Markets under the ticker symbol CBIH, today announced the appointment of Mr. Andy Trivedi, MBA, to its Board of Directors. The addition of Mr. Trivedi marks a strategic step forward in the Company's mission to scale operations, expand access to capital, and enhance long-term shareholder value.
A decorated U.S. Marine Corps veteran and seasoned financial strategist, Mr. Trivedi brings over two decades of leadership experience spanning Fortune 500 corporations, entrepreneurial ventures, and emerging growth sectors. His expertise in capital raising, financial structuring, and corporate growth strategy will directly support CBIH's plans for expansion and innovation in the rapidly evolving biomedical cannabis industry.
Mr. Trivedi currently serves as Chief Financial Officer of Newable Power LLC, where he has successfully led capital development and financial planning for high-growth energy ventures. His prior leadership roles at Hewlett-Packard, GE, Air Liquide, Siemens, and FMC underscore a proven track record in building scalable business models and forging strategic partnerships across global industries.
As a member of the Board, Mr. Trivedi will lead CBIH's efforts in capital strategy, investor engagement, and long-term corporate development, reinforcing the Company's ability to attract institutional partners and advance its position in medical cannabis research.
"The appointment of Mr. Andy Trivedi to our Board comes at a defining moment for CBIH," said Mr. John Jones, Treasurer and Director. "While the industry has been challenging to navigate, constraints on the resources required to scale—not capability—have delayed our product rollouts. Andy's proven guidance in complex financial markets will serve as a catalyst, helping us open new avenues of support, advance strategic collaborations, connect with additional financial partners, and secure the backing we need now to bring our products to market, all while maintaining our standards of safety, efficacy, and innovation."
Mr. Trivedi earned his MBA in Strategic Management from the UHV and a BBA in Risk Management and Finance from the UHD. In addition to his corporate achievements, he has been an active supporter of veteran initiatives and small business development programs, underscoring his commitment to community and sustainable growth.
By integrating proven financial leadership into its governance structure, CBIH is positioning itself to seize upcoming opportunities in the medical cannabis sector and deliver sustainable value for shareholders.
About Cannabis Bioscience International Holdings, Inc.
CBIH focuses on driving the science, safety, and effectiveness of cannabinoid-driven treatments. Through educational initiatives, clinical studies, and breakthrough product development, the company intends to improve patient care, inspire investor confidence, and set a higher bar for medical cannabis.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information, contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/269146
FAQ**
How will the appointment of Mr. Andy Trivedi to the board of Cannabis Bioscience International Holdings Inc CBIH impact the company's capital strategy and efforts to engage with institutional investors in Houston's evolving cannabis market?
What specific strategies will Cannabis Bioscience International Holdings Inc CBIH implement to navigate the regulatory challenges surrounding medical cannabis in Houston, especially with Mr. Trivedi's financial expertise?
In what ways does Cannabis Bioscience International Holdings Inc CBIH plan to leverage its operations in Houston to enhance the development and safety of cannabinoid-driven treatments?
How does Cannabis Bioscience International Holdings Inc CBIH's commitment to community and veteran initiatives align with broader economic development goals in Houston, particularly within the biomedical sector?
**MWN-AI FAQ is based on asking OpenAI questions about Cannabis Bioscience International Holdings Inc (OTC: CBIH).
NASDAQ: CBIH
CBIH Trading
0.0% G/L:
$0.0004 Last:
418,900 Volume:
$0.0005 Open:
